Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease

Epsilon Toxin Is Essential for the Virulence of Clostridium perfringens Type D Infection in Sheep, Goats, and Mice

(2013) J. P. Garcia et al.   INFECTION AND IMMUNITY

Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis

(2013) Elisa Schneider et al.   PLoS One

Attack of the nervous system by Clostridium perfringens Epsilon toxin: From disease to mode of action on neural cells

(2013) Laetitia Wioland et al.   TOXICON

Medical aspects of bio-terrorism

(2013) Mahdi Balali-Mood et al.   TOXICON

Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica

(2013) Jeffrey M. Gelfand et al.   JAMA Neurology

Oligodendrocytes and the early multiple sclerosis lesion

(2012) John W. Prineas et al.   ANNALS OF NEUROLOGY

Microcystic macular oedema in multiple sclerosis is associated with disease severity

(2012) J. M. Gelfand et al.   BRAIN

Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study

(2012) Shiv Saidha et al.   LANCET NEUROLOGY

Characterization of the high affinity binding of epsilon toxin from Clostridium perfringens to the renal system

(2012) Jonatan Dorca-Arévalo et al.   VETERINARY MICROBIOLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Molecular basis of toxicity of Clostridium perfringens epsilon toxin

(2011) Monika Bokori-Brown et al.   FEBS Journal

Epsilon toxin: a fascinating pore-forming toxin

(2011) Michel R. Popoff   FEBS Journal

Crystal Structure ofClostridium perfringensEnterotoxin Displays Features of β-Pore-forming Toxins

(2011) Kengo Kitadokoro et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Trapping a translocating protein within the anthrax toxin channel: implications for the secondary structure of permeating proteins

(2011) Daniel Basilio et al.   JOURNAL OF GENERAL PHYSIOLOGY

Diagnosis of Clostridium Perfringens Intestinal Infections in Sheep and Goats

(2011) Francisco A. Uzal et al.   JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION

Evidence for a Prepore Stage in the Action of Clostridium perfringens Epsilon Toxin

(2011) Susan L. Robertson et al.   PLoS One

Sialidases Affect the Host Cell Adherence and Epsilon Toxin-Induced Cytotoxicity of Clostridium perfringens Type D Strain CN3718

(2011) Jihong Li et al.   PLoS Pathogens

Molecular cloning and expression of epsilon toxin from Clostridium perfringens type D and tests of animal immunization

(2010) A.M. Souza et al.   GENETICS AND MOLECULAR RESEARCH

A review of cutaneous anthrax and its outcome

(2010) Mehmet Doganay et al.   Journal of Infection and Public Health

Breakdown of the blood-retinal barrier in multiple sclerosis measured by vitreous fluorophotometry

(2009) Tine Engell et al.   ACTA OPHTHALMOLOGICA

Immunoglobulins and complement in postmortem multiple sclerosis tissue

(2009) Michael H. Barnett et al.   ANNALS OF NEUROLOGY

Clostridial toxins

(2009) Michel R Popoff et al.   Future Microbiology

Clostridium perfringens Epsilon Toxin Increases the Small Intestinal Permeability in Mice and Rats

(2009) Jorge Goldstein et al.   PLoS One

Clostridium perfringens toxin genotypes in the feces of healthy North Americans

(2008) Robert J. Carman et al.   ANAEROBE

Sizing the Bacillus anthracis PA63 Channel with Nonelectrolyte Poly(Ethylene Glycols)

(2008) Brian J. Nablo et al.   BIOPHYSICAL JOURNAL

MRI in multiple sclerosis: current status and future prospects

(2008) Rohit Bakshi et al.   LANCET NEUROLOGY

Binding of ɛ-toxin from Clostridium perfringens in the nervous system

(2008) Jonatan Dorca-Arévalo et al.   VETERINARY MICROBIOLOGY